Physician profile
Heidi Kind Wolf
NPI 1902912033
$1,341.76
in general payments reported to CMS, 2019-2025
16 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $57.51 · 2021: $52.55 · 2022: $153 · 2023: $229 · 2024: $318 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $288.54 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $282.64 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $128.47 | 2022-2024 | Freestyle Libre 3 |
| Abbvie INC. | $125.34 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $121.86 | 2024-2025 | Farxiga, Airsupra |
| Genentech USA, INC. | $109.42 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.94 | 2019 | |
| Amgen INC. | $49.41 | 2019 | |
| Sanofi Pasteur INC. | $30.16 | 2019-2022 | |
| Pfizer INC. | $25.44 | 2019-2021 | |
| Seqirus USA INC | $20.75 | 2025 | Flucelvax, Fluad |
| Merck Sharp & Dohme LLC | $15.16 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $15.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.12 | 2022 | |
| Allergan, INC. | $12.04 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Kind Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.